These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 12116826

  • 1. Modern strategies to prevent coronary restenosis.
    Chieffo A, Stankovic G, Colombo A.
    Ital Heart J; 2002 Jun; 3 Suppl 4():9S-15S. PubMed ID: 12116826
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Randomized trial versus registry data--comparing apples and ORCHIDs.
    Moliterno DJ.
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):669-70. PubMed ID: 17039505
    [No Abstract] [Full Text] [Related]

  • 5. Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.
    Dobesh PP, Stacy ZA, Ansara AJ, Enders JM.
    Pharmacotherapy; 2004 Nov; 24(11):1554-77. PubMed ID: 15537561
    [Abstract] [Full Text] [Related]

  • 6. Peeling-off labels mounting evidence for benefit of drug-eluting stents with off-label use.
    Büttner HJ, Neumann FJ.
    J Am Coll Cardiol; 2007 Nov 20; 50(21):2037-8. PubMed ID: 18021869
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Restenosis in percutaneous coronary intervention--is drug-eluting stent the answer?
    Lim VY, Lim YL.
    Singapore Med J; 2003 Sep 20; 44(9):482-7. PubMed ID: 14740779
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Drug-eluting stents and other anti-restenosis devices].
    Moreno R.
    Rev Esp Cardiol; 2005 Jul 20; 58(7):842-62. PubMed ID: 16022816
    [Abstract] [Full Text] [Related]

  • 11. [Treatment and prevention of restenosis after percutaneous coronary intervention. Balloons, stents, radioactive rays and drug-releasing stents].
    Maeng M, Thuesen L, Andersen HR.
    Ugeskr Laeger; 2005 Aug 15; 167(33):3030-2. PubMed ID: 16109244
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique".
    Galassi AR, Colombo A, Buchbinder M, Grasso C, Tomasello SD, Ussia GP, Tamburino C.
    Catheter Cardiovasc Interv; 2007 Jun 01; 69(7):976-83. PubMed ID: 17295334
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Drug-eluting stents in coronary arteries. The risk of restenosis is drastically reduced].
    Tornvall P.
    Lakartidningen; 2004 Dec 23; 101(51-52):4175. PubMed ID: 15658586
    [No Abstract] [Full Text] [Related]

  • 18. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.
    Yarkoni A, Brodsky A, Sabapathy R, Pershad A.
    Indian Heart J; 2008 Dec 23; 60(3):195-9. PubMed ID: 19240306
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Drug-eluting stents: clinical experiences and perspectives.
    Grube E, Gerckens U, Buellesfeld L.
    Minerva Cardioangiol; 2002 Oct 23; 50(5):469-73. PubMed ID: 12384629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.